INTRODUCTION
============

Spasticity is generally conceptualized as a symptom of the upper motor neuron lesion. It is characterized by an exaggeration of the stretch reflex, spasms and resistance to passive movement across a joint, secondary to the hyperexcitability of spinal reflexes \[[@B1][@B2][@B3][@B4][@B5][@B6]\]. A complete loss of descending corticospinal projections is rare in patients with clinical signs of spasticity after spinal cord injury (SCI). Preserved propriospinal and supraspinal input to a given segmental level may explain why spasticity is a frequent consequence in SCI \[[@B1]\]. One hypothesis on the pathophysiology of spasticity highlights the important role of long-term reductions in segmental inhibition rather than primary increases in excitation.

Precise evaluation of spasticity is crucial to establish the efficacy of medical and physical therapeutic interventions. Various diagnostic methods are available to investigate specific influences of spasticity on muscles. The most obvious diagnosis of spasticity is based on the clinical assessment of muscle tone by a physician or physiotherapist, such as the Original Ashworth Scale (AS) \[[@B5]\] and the Modified Tardieu Scale. Spasticity has a neural component that is evoked by a velocity-dependent phenomenon. It also has a biomechanical component, such as soft-tissue compliance, i.e., stiffness \[[@B6]\]. Many studies showed that stiffness increased in spastic muscles due to changes in fiber type transformation. Morphometric and histochemical investigations show changes in mechanical muscle-fiber properties that might contribute to spastic muscle tone \[[@B7][@B8][@B9][@B10][@B11][@B12]\]. Changes in biomechanical conditions of a muscle might also have an important effect on the spasticity in people with SCI.

Acoustic radiation force impulse (ARFI) imaging utilizes ultrasound elastography technology, hence it is an ideal tool to noninvasively estimate the clinical field tissue stiffness. ARFI is achieved by mechanically exciting tissues with a localized impulsive radiation force. This results in shear wave propagation away from the region of excitation \[[@B13]\]. Shear wave velocity (SWV) is directly correlated with tissue stiffness. In general, greater SWV correlates with stiffer tissue. ARFI imaging has been used to study a variety of tissues, including liver \[[@B14]\], breast \[[@B15]\], kidney \[[@B16]\], spleen \[[@B17]\], prostate \[[@B18]\], pancreas \[[@B19]\], testes \[[@B20]\], thyroid \[[@B21]\], and muscle and tendon \[[@B22]\]. The most notable application of ARFI is the detection of liver fibrosis \[[@B23][@B24]\], because the fibrous tissues are usually stiffer than the surrounding tissues \[[@B25]\]. However, there is a lack of ARFI application to the spasticity of musculoskeletal tissues.

The aim of this study was to investigate intrinsic viscoelastic changes using SWV of spastic lower extremity muscles in patients with early SCI via ARFI and to evaluate correlation between the SWV values and spasticity.

MATERIALS AND METHODS
=====================

Subjects
--------

Eighteen patients undergoing rehabilitation treatment after having finished the acute stage of treatment for SCI were recruited. This study was limited to subjects with cervical spinal injury. Disease duration was within 3 months in all included patients since the focus of the study was early intrinsic viscoelastic changes of spastic lower extremity muscles in patients with SCI. Patients were divided into 2 groups, group A (mean age, 53.6±22.7 years; 5 males, 5 females; mean height, 163.7±9.1 cm; mean weight, 62.4±8.26 kg) included patients with spasticity and group B (mean age, 52.5±15.5 years; 5 males, 3 females; mean height, 167.7±12.1 cm; mean weight, 64.9±11.2 kg) included patients without spasticity ([Table 1](#T1){ref-type="table"}). Exclusion criteria were 1) previous botulinum toxin type A injection to the medial gastrocnemius muscle (GCM) or the long head of the biceps femoris muscle (BFLH), 2) fixed ankle or knee contracture, or 3) previous surgery of the lower limbs. Ten healthy adults without neurologic or musculoskeletal disabilities were included as a control group (group C; mean age, 42.7±14.2 years; 6 males, 4 females; mean height, 170.8±6.21 cm; mean weight, 66.9±8.1 kg) ([Table 2](#T2){ref-type="table"}).

Method
------

We applied the ARFI technique and measured the SWV of the GCM and the BFLH. We used the AS to assess the spasticity of the ankle and knee joints.

### ARFI technique

The examination started with a conventional ultrasound followed by ARFI. One experienced physician performed examination with a ACUSON S2000 ultrasound system (Siemens Healthcare, Erlangen, Germany) with linear probes (9L4). The positioning of the patients for imaging was identical to that used for standard clinical scanning. Scans of the short axis of the GCM and BFLH were performed with minimal compression applied with the transducer weight, bilaterally.

Three trials of ARFI imaging were performed and the mean of 3 SWVs was used. All subjects were scanned on an examination platform in the prone position with feet hanging over the edge. Ultrasound were repeatedly performed at the fixed point of the medial GCM, which was located at the middle of 2 reference points (1 point was located at the proximal one third of a longitudinal line from midway between the medial and lateral malleoli to midway between the medial and lateral epicondyles; the other point was located at the medial end on a transverse line perpendicular to the point on the longitudinal line) and performed at the BFLH, which was located at the midpoint between ischial tuberosity and lateral condyle of tibia. Scanning was discontinued whenever reflexive or voluntary contraction of the lower limb muscles was visually apparent. The target muscle was displayed in B-mode and the region of interest (ROI) was subsequently identified in the muscle. ARFI technology uses short-duration acoustic radiation forces to generate localized tissue displacement, which results in shear-wave propagation \[[@B7]\]. The ROI is characterized by a box with a fixed dimension of 0.5 cm^2^ for ARFI measurements during real-time B-mode imaging. The shear waves propagate perpendicular to the acoustic pulse, away from the target ROI. The velocity of the shear wave speed is expressed in m/s ([Fig. 1](#F1){ref-type="fig"}).

### Assessment of spasticity

The spasticity of the ankle plantar flexor muscles in patients with spasticity was measured as the degree of resistance to passive movement felt by the physical therapist using the AS, with a rating from 0 to 4 (0, hypotonic; 4, extreme resistance).

### Statistical analysis

One-way analysis of variance (ANOVA) was used for comparison of SWV among the 3 groups (patients with spasticity, patients without spasticity and healthy subjects), whereas Tukey Honestly Significant Difference (HSD) was used for multiple comparisons. Between-group comparisons for continuous data were assessed with Mann-Whitney U test when appropriate. We evaluated correlation of spasticity with SWV by assessing the Spearman rank correlation coefficients. The interclass correlation coefficient was used to examine intra-rater reliability of repeated ARFI.

Data were expressed as the mean±standard deviation. Statistical significance was set at p\<0.05. All statistical tests were conducted using the SPSS ver. 18.0 (SPSS Inc., Chicago, IL, USA).

RESULTS
=======

SWV
---

Patients with spasticity had significantly faster SWV for GCM and BFLH than those without spasticity (Mann-Whitney U test, p=0.007 and p=0.008) and normal control (p=0.011 and p=0.037, respectively) ([Fig. 2](#F2){ref-type="fig"}). The SWVs of the GCM (1.15±0.45 m/s) and BFLH (1.43±0.76 m/s) in spastic patients was significantly higher, as compared with that of patients without spasticity (GCM, 0.66±0.08 m/s; BFLH, 0.73±0.19 m/s) and healthy subjects (GCM, 0.74±0.13 m/s; BFLH, 0.77±0.18 m/s). Interclass correlation coefficient for GCM was 0.85 and interclass correlation coefficient for BFLH was 0.79, respectively.

Correlation between SWV and spasticity
--------------------------------------

The SWV values for the GCM correlated with ankle spasticity (Spearman rank test, p=0.026). There were significant correlations between the SWV values for the long head of biceps femoris muscle and knee spasticity (Spearman rank test, p=0.022) ([Table 3](#T3){ref-type="table"}).

DISCUSSION
==========

We examined the correlation between the speed of the SWV and spasticity in patients with SCI. We assumed that the SWV of spastic muscle would be fast, as compared with patients without spasticity, these assumptions were established based on the knowledge that the SWV reflects the extent of hardness or stiffness, because GCM and BFLH in patients with spasticity become hard and stiff \[[@B8][@B10][@B12][@B26][@B27]\]. The SWVs of the BFLH and GCM with spasticity in patients who had SCI were statistically significantly faster, as compared with healthy adults. This result indicated that spastic muscle was hard and stiff, as compared with non-spastic muscles, because SWV is proportionate to tissue hardness. These findings supported the hypothesis that the degree of elasticity of tissue changes after SCI and the muscles become stiffer in SCI patients who have spasticity.

Our findings were consistent with other studies, which found that the degree of ankle spasticity was correlated with stiffness of the medial GCM in children with spastic cerebral palsy \[[@B28]\]. The SWV of the GCM in the group with spastic cerebral palsy was significantly higher than that in the group without neurologic and musculoskeletal disabilities \[[@B28]\].

We found a statistically significant positive correlation between SWVs and the AS score of spastic muscles. This indicated that SWV is fast when spasticity is high. Many studies reported that the total amount of collagen content and expression of genes that are involved in the conversion of collagen from the tissue, such as LH2b and TGF-β1were increased in spastic muscle; and muscle fiber type transformation was observed in the post SCI patient group \[[@B29][@B30][@B31]\]. Based on these studies, we could predict that the degree of stiffness was increased in spastic muscle and we can measure the spasticity by SWV with ARFI, indirectly.

Most research on skeletal muscle spasticity has focused on the neural changes. It is reasonable because the primary cause leading to spasticity is located in the central nervous system \[[@B12]\]. In our study, 3 patients who had SCI showed low SWV (0.72, 0.71, and 0.65 m/s) although they had spasticity (AS grade of GCM was 1 and 2). Muscle and neural changes are usually related, but probably to differing extents, depending on the particular disease state, patient age, and time since injury. We thought that 3 patients had more neural changes, such as neurally mediated reflex stiffness, and less structural change. The other 7 patients showed high SWV in spastic GCM and BFLH that may be reflect more structural change such as stiffness and hardness than neural changes.

Scelsi \[[@B31]\] reported that muscle atrophy and muscle fiber type transformation in their fundamental properties occur in early SCI supporting the presence of progressive changes in muscles probably occurring early after cord injury. In our study, the ARFI-SWV values of spastic muscle were estimated as high in the early stage of SCI. This result indicating that increased muscle stiffness could occur at early stages post SCI was consistent with the previous study.

A greater number of test subjects will be required in future studies to evaluate spasticity by SWV adding to AS, the continuous variables (e.g., Spinal Cord Assessment Tool for Spastic Reflexes) as an accessory measurement of spasticity for neural and structural change in SCI patients.

ARFI is a convenient tool and has the advantage of being able to quantify the structural change such as stiffness and hardness of the tissue by measuring the SWV. It will therefore be a useful tool to measure the degree of stiffness of muscles with spasticity. Guzman-Aroca et al. \[[@B32]\] noted that SWV measured by ARFI has high intraexaminer reliability and high reproducibility.

Our study had limitations. Firstly, the number of subjects was small so statistical power was low and we were not able to perform a double-blind study to evaluate spasticity by the AS score and ARFI. Secondly, it was not possible to examine the relationship between the change in hardness and elasticity of the muscles and disease duration because SCI patients in our study were diagnosed within 3 months. Finally, only 1 observer performed 1 session for each compression condition. More investigations are needed to establish the inter-observer reliability of the SWV measurements.

However, this study is the first study to investigate spastic muscles in SCI patients using ARFI and SWV detection and evaluate correlation between the SWV values and spasticity in SCI patients. It has not been conducted in other clinical studies.

We focused on reducing muscle stiffness by stretching for treatment of the spasticity especially on muscle with estimated high SWV via ARFI. Further study with a larger sample size and an evaluation of the correlation between the SWV of muscle and the disease period of SCI is needed to confirm the validity of these study results.

In conclusion, this study proves the feasibility of quantifying spastic muscle stiffness with ARFI in SCI patients. ARFI demonstrated a difference in muscle stiffness between patients with spasticity and those without spasticity in SCI. These findings suggested that stiffness of muscles could be increased in spastic lower extremity of early SCI patients as well as chronic SCI patients.

ARFI imaging performed by an expert physiatrist is a valuable tool that can be used to noninvasively evaluate the spasticity of the muscle in SCI patients with AS. Furthermore, it has the potential to identify structural changes of the tissue associated with spasticity.
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###### Characteristics of groups A and B

![](arm-39-393-i001)

AIS, American Spinal Injury Association impairment scale using the International Standards for Neurological Classification of Spinal Cord Injury; AS, original Ashworth Scale.

^a)^Patient with spinal cord injury and spasticity. ^b)^Patient with spinal cord injury and no spasticity.

###### Characteristics of the subjects
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Values are presented as number or mean±standard deviation.

AS, original Ashworth Scale; PF, plantar flexor.

^a)^Patient with spinal cord injury and spasticity. ^b)^Patient with spinal cord injury and no spasticity. ^c)^Healthy adults.

###### Correlation of spasticity and SWV
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SWV, shear wave velocity; GCM, gastrocnemius muscle; AS, original Ashworth Scale; BFLH, long head of biceps femoris muscle.

^\*^p\<0.05 by Spearman rho test.
